Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures

Andrade, Marcus Vinicius Santos; Andrade, Luciana Azevedo Prata; Bispo, Alan Freitas; Freitas, Luana de Alencar; Andrade, Milena Quadros Sampaio; Feitosa, Gilson Soares; Feitosa-Filho, Gilson Soares.
Arq. bras. cardiol ; 111(3): 394-399, Sept. 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-973752

Documentos relacionados

  1. Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures.
  2. Plasma Drug Values of DOACs in Patients Presenting with Gastrointestinal Bleeding: A Prospective Observational Study.
  3. Direct oral anticoagulants and their antagonists in perioperative practice.
  4. Gastrointestinal Bleeding Due to NOACs Use: Exploring the Molecular Mechanisms.
  5. The Safety of Continued Oral Anticoagulation Therapy in Joint Injections and Aspirations: A Qualitative Review of the Current Evidence.
  6. Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study.
  7. Clinical Relevance of Preclinical and Clinical Studies of Four-Factor Prothrombin Complex Concentrate for Treatment of Bleeding Related to Direct Oral Anticoagulants.
  8. Effectiveness and Safety of Contemporary Oral Anticoagulants Among Asians With Nonvalvular Atrial Fibrillation.
  9. Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants.
  10. Review Article: Gastrointestinal Bleeding Risk with Direct Oral Anticoagulants.